Concepedia

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE)

Marcelo Silva, Jorge Luis Poo, Frank Wagner, Mary L. Jackson, David L. Cutler, Michael J. Grace, Ronald Bordens, Connie Cullen, Joann Harvey, Mark Laughlin

Journal of Hepatology · 2006 · 106 citations · 13 references

DOI

Concepts

References

13

Rising Incidence of Hepatocellular Carcinoma in the United States

Hashem B. El‐Serag, Andrew C. Mason · New England Journal of Medicine · 1999 · 2.9K citations

, , +9

Rational Design of a Potent, Long-Lasting Form of Interferon:  A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis C

Pascal Bailon, Alicia V. Palleroni, Carol Ann Schaffer et al. · Bioconjugate Chemistry · 2001 · 611 citations

, , +16

Estimating future hepatitis C morbidity, mortality, and costs in the United States

John B. Wong, Geraldine M. McQuillan, John G. McHutchison et al. · American Journal of Public Health · 2000 · 570 citations · Full text

, , +16

The uses and properties of PEG-linked proteins.

Cristina Delgado, G. E. Francis, Derek Fisher · PubMed · 1992 · 424 citations

, , +14

Structural and Biologic Characterization of Pegylated Recombinant IFN- <i>α</i> 2b

Michael J. Grace, Stephen K. Youngster, Gerry Gitlin et al. · Journal of Interferon & Cytokine Research · 2001 · 174 citations

, , +17